ASH 2018 Prof dr. van de Loosdrecht

Prof dr. Arjan van de Loosdrecht, internist-hematoloog, Amsterdam UMC, Amsterdam

 

Safety and Efficacy, Including Event-Free Survival, of Deferasirox Versus Placebo in Iron-Overloaded Patients with Low- and Int-1-Risk Myelodysplastic Syndromes (MDS): Outcomes from the Randomized, Double-Blind Telesto Study

 

https://ash.confex.com/ash/2018/webprogram/Paper111134.html
 

 

 

0119HEM1092342
×

Ask Speakers

×

Medical Information Request